PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation

Epigenetics

Volumn 7, Issue 11, 2012, Pages 1315-1330

  Venza, Isabella ^a   Visalli, Maria ^a   Fortunato, Cinzia ^a   Ruggeri, Manuela ^a   Ratone, Simona ^a   Caffo, Maria ^a   Caruso, Gerardo ^a   Alafaci, Concetta ^a   Tomasello, Francesco ^a   Teti, Diana ^a   Venza, Mario ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Astrocytoma; DNA demethylation; Histone acetylation; IL 8; PGE2

Indexed keywords

EID: 84868347063     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.22446     Document Type: Article

References (58)

1. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science 1999. 286:481-486. PMID:10521337. http://dx.doi.org/10.1126/science.286.5439.481.
2. Jenuwein T, Allis CD. Translating the histone code. Science 2001. 293:1074-1080. PMID:11498575. http://dx.doi.org/10.1126/science.1063127.
3. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004. 429:457-463. PMID:15164071. http://dx.doi.org/10.1038/nature02625.
4. Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 2012. 22:50-55. PMID:22402447. http://dx.doi.org/10.1016/j.gde.2012.02.008.
5. nd IARC meeting, Lyon, France, 6 and 7 December 2007. Mol Oncol 2008. 2:33-40. PMID:19383327. http://dx.doi.org/10.1016/j.molonc.2008.03.005.
6. Park YJ, Claus R, Weichenhan D, Plass C. Genome wide epigenetic modifications in cancer. Prog Drug Res 2011. 67:25-49. PMID:21141723.
7. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006. 31:89-97. PMID:16403636. http://dx.doi.org/10.1016/j.tibs.2005.12.008.
8. Vaissière T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 2008. 659:40-48. PMID:18407786. http://dx.doi.org/10.1016/j.mrrev.2008.02.004.
9. Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, et al. Identification of interleukin-8 as estrogen receptorregulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 2004. 109:507-515. PMID:14991571. http://dx.doi.org/10.1002/ijc.11724.
10. Yao C, Lin Y, Chua MS, Ye CS, Bi J, Li W, et al. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer 2007. 121:1949-1957. PMID:17621625. http://dx.doi.org/10.1002/ijc.22930.
11. Wang XB, Tian XY, Li Y, Li B, Li Z. Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. J Neurooncol 2012. 106:43-51. PMID:21725855. http://dx.doi.org/10.1007/s11060-011-0640-3.
12. Piperi C, Samaras V, Levidou G, Kavantzas N, Boviatsis E, Petraki K, et al. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry. Cytokine 2011. 55:387-395. PMID:21684758. http://dx.doi.org/10.1016/j.cyto.2011.05.012.
13. Bonavia R, Inda MM, Vandenberg S, Cheng SY, Nagane M, Hadwiger P, et al. EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway. Oncogene 2011. 31:4054-4066. PMID:22139077. http://dx.doi.org/10.1038/onc.2011.563.
14. Venza M, Visalli M, Alafaci C, Caffo M, Caruso G, Salpietro FM, et al. Interleukin-8 overexpression in astrocytomas is induced by prostaglandin E2 and is associated with the transcription factors CCAAT/enhancer-binding protein-β and CCAAT/enhancerbinding homologous protein. Neurosurgery 2011. 69:713-721, discussion 721. PMID:21471847. http://dx.doi.org/10.1227/NEU.0b013e31821954c6.
15. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004. 305:1289-1292. PMID:15297624. http://dx.doi.org/10.1126/science.1101372.
16. Mink S, Haenig B, Klempnauer KH. Interaction and functional collaboration of p300 and C/EBPbeta. Mol Cell Biol 1997. 17:6609-6617. PMID:9343424.
17. Kovács KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR. CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation. J Biol Chem 2003. 278:36959-6965. PMID:12857754. http://dx.doi.org/10.1074/jbc.M303147200.
18. Cui TX, Piwien-Pilipuk G, Huo JS, Kaplani J, Kwok R, Schwartz J. Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation. Mol Endocrinol 2005. 19:2175-2186. PMID:15860545. http://dx.doi.org/10.1210/me.2004-0502.
19. Glaser KB. HDAC inhibitors: clinical update and mechanism-based potential. Biochem Pharmacol 2007. 74:659-671. PMID:17498667. http://dx.doi.org/10.1016/j.bcp.2007.04.007.
20. Li X, Kaplun A, Lonardo F, Heath E, Sarkar FH, Irish J, et al. HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells. Mol Cancer Res 2011. 9:733-745. PMID:21622623. http://dx.doi.org/10.1158/1541-7786.MCR-10-0505.
21. Jin JS, Tsao TY, Sun PC, Yu CP, Tzao C. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin. Pathol Oncol Res 2012. 18:713-720. PMID:22270866. http://dx.doi.org/10.1007/s12253-012-9499-7.
22. Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C, et al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 2007. 26:412-423. PMID:17245431. http://dx.doi.org/10.1038/sj.emboj.7601516.
23. Payner T, Leaver HA, Knapp B, Whittle IR, Trifan OC, Miller S, et al. Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E(2)-dependent activation of type II protein kinase A. Mol Cancer Ther 2006. 5:1817-1826. PMID:16891468. http://dx.doi.org/10.1158/1535-7163.MCT-05-0548.
24. Samaras V, Piperi C, Levidou G, Zisakis A, Kavantzas N, Themistocleous MS, et al. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry. Hum Immunol 2009. 70:391-397. PMID:19332096. http://dx.doi.org/10.1016/j.humimm.2009.03.011.
25. Strieter RM, Belperio JA, Burdick MD, Sharma S, Dubinett SM, Keane MP. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann N Y Acad Sci 2004. 1028:351-360. PMID:15650260. http://dx.doi.org/10.1196/annals.1322.041.
26. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 2004. 25:201-209. PMID:15039047. http://dx.doi.org/10.1016/j.it.2004.02.006.
27. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 2003. 284:L566-L577. PMID:12618418.
28. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008. 14:6735-6741. PMID:18980965. http://dx.doi.org/10.1158/1078-0432.CCR-07-4843.
29. Dimberg J, Ström K, Löfgren S, Zar N, Lindh M, Matussek A. DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas. Int J Colorectal Dis 2011. 27:709-714. PMID:22108905.
30. Andia DC, de Oliveira NF, Casarin RC, Casati MZ, Line SR, de Souza AP. DNA methylation status of the IL8 gene promoter in aggressive periodontitis. J Periodontol 2010. 81:1336-141. PMID:20450371. http://dx.doi.org/10.1902/jop.2010.100082.
31. Oliveira NF, Damm GR, Andia DC, Salmon C, Nociti FH Jr., Line SR, et al. DNA methylation status of the IL8 gene promoter in oral cells of smokers and nonsmokers with chronic periodontitis. J Clin Periodontol 2009. 36:719-725. PMID:19659670. http://dx.doi.org/10.1111/j.1600-051X.2009.01446.x.
32. De Larco JE, Wuertz BR, Yee D, Rickert BL, Furcht LT. Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Proc Natl Acad Sci U S A 2003. 100:13988-13993. PMID:14623984. http://dx.doi.org/10.1073/pnas.2335921100.
33. Angrisano T, Pero R, Peluso S, Keller S, Sacchetti S, Bruni CB, et al. LPS-induced IL-8 activation in human intestinal epithelial cells is accompanied by specific histone H3 acetylation and methylation changes. BMC Microbiol 2010. 10:172. PMID:20546607. http://dx.doi.org/10.1186/1471-2180-10-172.
34. Tong KM, Shieh DC, Chen CP, Tzeng CY, Wang SP, Huang KC, et al. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts. Cell Signal 2008. 20:1478-1488. PMID:18501560. http://dx.doi.org/10.1016/j.cellsig.2008.04.003.
35. Pollack BP, Sapkota B, Boss JM. Ultraviolet radiation-induced transcription is associated with genespecific histone acetylation. Photochem Photobiol 2009. 85:652-662. PMID:19076306. http://dx.doi.org/10.1111/j.1751-1097.2008.00485.x.
36. Slevogt H, Schmeck B, Jonatat C, Zahlten J, Beermann W, van Laak V, et al. Moraxella catarrhalis induces inflammatory response of bronchial epithelial cells via MAPK and NF-kappaB activation and histone deacetylase activity reduction. Am J Physiol Lung Cell Mol Physiol 2006. 290:L818-L826. PMID:16399788. http://dx.doi.org/10.1152/ajplung.00428.2005.
37. Xia D, Wang D, Kim SH, Katoh H, DuBois RN. Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med 2012. 18:224-226. PMID:22270723. http://dx.doi.org/10.1038/nm.2608.
38. Huang SK, Scruggs AM, Donaghy J, McEachin RC, Fisher AS, Richardson BC, et al. Prostaglandin E2 increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB J 2012. 26:3703-3714. PMID:22645246. http://dx.doi.org/10.1096/fj.11-203323.
39. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986. 321:209-213. PMID:2423876. http://dx.doi.org/10.1038/321209a0.
40. Chavey C, Mühlbauer M, Bossard C, Freund A, Durand S, Jorgensen C, et al. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer. Mol Pharmacol 2008. 74:1359-1366. PMID:18669446. http://dx.doi.org/10.1124/mol.108.047332.
41. Böcker U, Nebe T, Herweck F, Holt L, Panja A, Jobin C, et al. Butyrate modulates intestinal epithelial cellmediated neutrophil migration. Clin Exp Immunol 2003. 131:53-60. PMID:12519386. http://dx.doi.org/10.1046/j.1365-2249.2003.02056.x.
42. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001. 15:1110-1112. PMID:11292684.
43. Wen X, Wu GD. Evidence for epigenetic mechanisms that silence both basal and immune-stimulated transcription of the IL-8 gene. J Immunol 2001. 166:7290-7299. PMID:11390479.
44. Adam E, Quivy V, Bex F, Chariot A, Collette Y, Vanhulle C, et al. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. Mol Cell Biol 2003. 23:6200-6229. PMID:12917341. http://dx.doi.org/10.1128/MCB.23.17.6200-6209.2003.
45. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001. 21:7065-7077. PMID:11564889. http://dx.doi.org/10.1128/MCB.21.20.7065-7077.2001.
46. Iwata K, Tomita K, Sano H, Fujii Y, Yamasaki A, Shimizu E. Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. Cell Immunol 2002. 218:26-33. PMID:12470611. http://dx.doi.org/10.1016/S0008-8749(02)00523-3.
47. Hoshimoto A, Suzuki Y, Katsuno T, Nakajima H, Saito Y. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Br J Pharmacol 2002. 136:280-286. PMID:12010777. http://dx.doi.org/10.1038/sj.bjp.0704719.
48. Klug M, Heinz S, Gebhard C, Schwarzfischer L, Krause SW, Andreesen R, et al. Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels. Genome Biol 2010. 11:R63. PMID:20565882. http://dx.doi.org/10.1186/gb-2010-11-6-r63.
49. Chiurazzi P, Pomponi MG, Pietrobono R, Bakker CE, Neri G, Oostra BA. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet 1999. 8:2317-2323. PMID:10545613. http://dx.doi.org/10.1093/hmg/8.12.2317.
50. D'Alessio AC, Weaver IC, Szyf M. Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes. Mol Cell Biol 2007. 27:7462-7474. PMID:17709385. http://dx.doi.org/10.1128/MCB.01120-07.
51. Hadizadeh S, King DN, Shah S, Sewer MB. Sphingosine-1-phosphate regulates the expression of the liver receptor homologue-1. Mol Cell Endocrinol 2008. 283:104-113. PMID:18191017. http://dx.doi.org/10.1016/j.mce.2007.11.030.
52. Sun HS, Hsiao KY, Hsu CC, Wu MH, Tsai SJ. Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor. Endocrinology 2003. 144:3934-3942. PMID:12933667. http://dx.doi.org/10.1210/en.2003-0289.
53. Lopes FL, Desmarais J, Ledoux S, Gévry NY, Lefevre P, Murphy BD. Transcriptional regulation of uterine vascular endothelial growth factor during early gestation in a carnivore model, Mustela vison. J Biol Chem 2006. 281:24602-24611. PMID:16790435. http://dx.doi.org/10.1074/jbc.M602146200.
54. Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-κB induced invasion by gliomas. J Neurooncol 2011. 101:227-235. PMID:20577780. http://dx.doi.org/10.1007/s11060-010-0261-2.
55. Auf G, Jabouille A, Guérit S, Pineau R, Delugin M, Bouchecareilh M, et al. Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci U S A 2010. 107:15553-15558. PMID:20702765. http://dx.doi.org/10.1073/pnas.0914072107.
56. Piperi C, Samaras V, Levidou G, Kavantzas N, Boviatsis E, Petraki K, et al. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry. Cytokine 2011. 55:387-395. PMID:21684758. http://dx.doi.org/10.1016/j.cyto.2011.05.012.
57. Mai A, Massa S, Pezzi R, Rotili D, Loidl P, Brosch G. Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. J Med Chem 2003. 46:4826-4829. PMID:14584932. http://dx.doi.org/10.1021/jm034167p.
58. Mai A, Massa S, Pezzi R, Simeoni S, Rotili D, Nebbioso A, et al. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. J Med Chem 2005. 48:3344-3353. PMID:15857140. http://dx.doi.org/10.1021/jm049002a.